Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed director
CC transcript
Inv. presentation
Director departure
Quarterly results

NEOGENOMICS INC (NEO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "NeoGenomics Reports Second Quarter 2023 Results"
06/29/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors"
05/30/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/17/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "PERFORMANCE STOCK UNIT AWARD AGREEMENT NEOGENOMICS, INC.",
"AMENDMENT TO EMPLOYMENT AGREEMENT"
05/08/2023 8-K Quarterly results
Docs: "NeoGenomics Reports First Quarter 2023 Results"
04/04/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "NHS, NSF, NIH, UN, WHO,"
02/23/2023 8-K Quarterly results
Docs: "NeoGenomics Reports Fourth Quarter and Full Year 2022 Results"
01/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/05/2022 8-K Quarterly results
11/18/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/08/2022 8-K Quarterly results
Docs: "NeoGenomics Reports Third Quarter 2022 Results"
11/07/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors"
10/20/2022 8-K Quarterly results
08/12/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
07/21/2022 8-K Quarterly results
06/03/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
05/06/2022 8-K Quarterly results
04/27/2022 8-K Quarterly results
Docs: "NeoGenomics Reports Revenue of $117 Million in the First Quarter"
04/25/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/14/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Key 2021 Financial Highlights and Accomplishm"
03/28/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement, by and between NeoGenomics, Inc. and Mark Mallon",
"NeoGenomics Announces CEO Departure and Initiates CEO Search Board Appoints Executive Chair and Interim Office of the CEO Anticipates First Quarter Results Below Guidance and Withdraws 2022 Guidance Ft. Myers, Florida—March 28, 2022 / NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that the Board of Directors and Mark Mallon, Chief Executive Officer, have agreed that Mr. Mallon will step down as CEO and member of the Board, effective immediately. This mutual agreement was not the result of any disagreements about strategy with management or the Board, inappropriate action by CEO, or any violation of company policy or any accounting irregularity. The Board has retained Russell Reynolds to condu..."
03/09/2022 8-K Quarterly results
02/23/2022 8-K Quarterly results
Docs: "NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021"
01/19/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/10/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/04/2021 8-K Quarterly results
Docs: "NeoGenomics Reports Revenue of $121 Million in the Third Quarter"
10/12/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "NeoGenomics Announces Board of Directors’ Transition"
08/10/2021 8-K Quarterly results
08/06/2021 8-K Quarterly results
Docs: "NeoGenomics Reports 40% Revenue Growth to $122 Million in the Second Quarter"
07/07/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/24/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy